黄类药物:一个潜在的药理学潜力的宝库
Hasin Hasnat1, Suriya Akter Shompa1, Md Mirazul Islam1
1Department of Pharmacy, State University of Bangladesh, 77 Satmasjid Road, Dhanmondi, Dhaka, 1207, Bangladesh.
Heliyon
|March 18, 2024
概括
在植物中发现的黄类化合物显示出潜在的健康益处,包括抗糖尿病和抗炎作用. 需要进一步的临床研究来了解它们的全部影响并优化治疗用途.
科学领域:
- * 植物化学和自然产品
- *药理学和治疗学 *药理学和治疗学
背景情况:
- * 黄酸是各种各样的化合物,在水果,蔬菜和饮料等自然来源中丰富.
- *七种常见的黄类化合物 (apigenin,galangin,hesperetin,kaempferol,myricetin,naringenin,quercetin) 是研究的主要对象.
- * 越来越多的人对提取黄类素的兴趣越来越大,因为它们已被证明具有健康益处.
研究的目的:
- * 审查常见的黄类药物的生物活性和治疗潜力.
- * 探索最近的趋势,干预措施和黄类药物在疾病治疗中的未来应用.
- * 确定研究缺口,并指导未来的药物发现工作.
主要方法:
- *从主要科学数据库 (PubMed,科学网,谷歌学者等) 的文献记录的综合文献综述. ) 的情况.
- *分析了来自体外,体内和临床研究的证据.
- * 综合有关黄类物质特性和应用的当前知识.
主要成果:
- * 黄类药物表现出有前途的抗糖尿病,抗炎,抗菌,抗氧化,抗病毒,细胞毒性和降脂活性.
- * 有证据支持它们在治疗糖尿病,炎症,感染,癌症和心血管疾病方面的潜力.
- *确定了基于黄类药物治疗的趋势,治疗干预措施和未来前景.
结论:
- * 黄类化合物是新药发现和治疗应用的一类有前途的化合物.
- * 临床研究仍然存在重大差距,特别是在高度和低度影响以及生物可用性方面.
- *未来的研究应该集中在生物可用性和临床疗效上,以充分利用黄类的潜力.
相关概念视频
01:22Dose-Response Relationship: Potency and Efficacy
4.4K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.4K
01:24Principles of Drug Action
6.0K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.0K
01:21Pharmacodynamics: Overview and Principles
1.1K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
1.1K
01:26Targets for Drug Action: Overview
6.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.2K
01:14Agonism and Antagonism: Quantification
369
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
369
01:28Structure-Activity Relationships and Drug Design
716
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
716